Home LiteratureArticle Details
PMID: 3513191 Published · ppublish English Journal Article

Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.

Elango N, Prince GA, Murphy BR, Venkatesan S, Chanock RM, Moss B

Abstract

A cDNA copy of the G glycoprotein gene of human respiratory syncytial virus (RSV) was placed under control of a vaccinia virus promoter and inserted into the thymidine kinase locus of the vaccinia virus genome. The recombinant vaccinia virus retained infectivity and expressed a 93-kDa protein that migrated with the authentic RSV G glycoprotein upon polyacrylamide gel electrophoresis. Glycosylation of the expressed protein and transport to the cell surface were demonstrated in the absence of other RSV proteins. Cotton rats that were inoculated intradermally with the infectious recombinant virus produced serum antibody to the G glycoprotein that neutralized RSV in vitro. Furthermore, the vaccinated animals were resistant to lower respiratory tract infection upon intranasal inoculation with RSV and had reduced titers of RSV in the nose.

MeSH Terms
Animals Arvicolinae Cell Line Chlorocebus aethiops Cloning, Molecular DNA/genetics DNA, Viral/genetics Disease Susceptibility Genetic Vectors Immunization Kidney Recombinant Proteins/genetics,immunology Respiratory Syncytial Viruses/genetics,immunology Respirovirus Infections/immunology,prevention & control T-Lymphocytes, Cytotoxic/immunology Vaccinia virus/genetics Viral Proteins/genetics,immunology
Chemicals
DNA, Viral Recombinant Proteins Viral Proteins DNA
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Elango N
Prince G A
Murphy B R
Venkatesan S
Chanock R M
Moss B
References (45)
45 references, click to expand
  1. Isolation of DNA from agarose gels using DEAE-paper. Application to restriction site mapping of adenovirus type 16 DNA.
    Nucleic Acids Res. 1980 Jan 25;8(2):253-64 PMID: 6252542
  2. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  3. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.
    J Pediatr. 1981 May;98(5):708-15 PMID: 7229749
  4. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    J Infect Dis. 1982 Mar;145(3):311-9 PMID: 7037983
  5. Maternal antibody and respiratory syncytial virus infection in infancy.
    J Med Virol. 1981;7(4):263-71 PMID: 7038043
  6. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
    Proc Natl Acad Sci U S A. 1982 Feb;79(4):1210-4 PMID: 6280173
  7. Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion.
    Infect Immun. 1982 Jul;37(1):243-9 PMID: 7107006
  8. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
    Proc Natl Acad Sci U S A. 1982 Aug;79(16):4927-31 PMID: 6289324
  9. A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments.
    Gene. 1982 Oct;19(3):269-76 PMID: 6295880
  10. Vaccinia virus: a selectable eukaryotic cloning and expression vector.
    Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9 PMID: 6296831
  11. The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes.
    J Immunol Methods. 1982 Dec 30;55(3):297-307 PMID: 6820029
  12. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
    Nature. 1983 Apr 7;302(5908):490-5 PMID: 6835382
  13. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.
    J Virol. 1983 Jul;47(1):171-7 PMID: 6345804
  14. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5364-8 PMID: 6310573
  15. Mechanisms of immunity to respiratory syncytial virus in cotton rats.
    Infect Immun. 1983 Oct;42(1):81-7 PMID: 6352505
  16. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
    Proc Natl Acad Sci U S A. 1983 Dec;80(23):7155-9 PMID: 6580632
  17. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.
    Infect Immun. 1984 Feb;43(2):756-8 PMID: 6363300
  18. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
    Proc Natl Acad Sci U S A. 1984 Jan;81(1):193-7 PMID: 6320164
  19. Monoclonal antibodies protect against respiratory syncytial virus infection in mice.
    Immunology. 1984 May;52(1):137-42 PMID: 6201436
  20. Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
    Nature. 1984 Sep 6-11;311(5981):67-9 PMID: 6472464
  21. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
    Nature. 1984 Oct 11-17;311(5986):578-9 PMID: 6332992
  22. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
    Science. 1985 May 10;228(4700):737-40 PMID: 2986288
  23. Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit.
    Nucleic Acids Res. 1985 Mar 11;13(5):1559-74 PMID: 2987829
  24. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4075-9 PMID: 3858865
  25. Respiratory syncytial virus polypeptides. V. The kinetics of glycoprotein synthesis.
    J Gen Virol. 1985 Jun;66 ( Pt 6):1241-7 PMID: 4009147
  26. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.
    J Virol. 1985 Sep;55(3):517-20 PMID: 4020957
  27. Kinetics of synthesis of respiratory syncytial virus glycoproteins.
    J Gen Virol. 1985 Sep;66 ( Pt 9):1983-90 PMID: 4031826
  28. Cytotoxic T-cell response to respiratory syncytial virus in mice.
    J Virol. 1985 Oct;56(1):55-9 PMID: 2411951
  29. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.
    J Infect Dis. 1985 Nov;152(5):1083-7 PMID: 4045247
  30. Multiple mechanisms of protein insertion into and across membranes.
    Science. 1985 Oct 25;230(4724):400-7 PMID: 4048938
  31. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.
    Nucleic Acids Res. 1985 Nov 11;13(21):7795-812 PMID: 4069997
  32. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
    Mol Cell Biol. 1985 Dec;5(12):3403-9 PMID: 3939316
  33. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.
    Proc Natl Acad Sci U S A. 1984 Nov;81(22):7194-8 PMID: 6095272
  34. Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.
    DNA. 1984 Dec;3(6):479-88 PMID: 6096101
  35. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 1984 Dec;81(24):7683-7 PMID: 6096849
  36. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.
    Science. 1985 Jan 25;227(4685):433-5 PMID: 2981435
  37. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9 PMID: 3872457
  38. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
    Am J Epidemiol. 1969 Apr;89(4):422-34 PMID: 4305198
  39. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
    Am J Epidemiol. 1973 Oct;98(4):289-300 PMID: 4355170
  40. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.
    J Infect Dis. 1976 Sep;134(3):211-7 PMID: 977992
  41. The pathogenesis of respiratory syncytial virus infection in cotton rats.
    Am J Pathol. 1978 Dec;93(3):771-91 PMID: 362946
  42. Visualization of an inverted terminal repetition in vaccinia virus DNA.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4863-7 PMID: 283397
  43. Respiratory syncytial virus polypeptides: their location in the virion.
    Virology. 1979 May;95(1):137-45 PMID: 442538
  44. A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
    Nucleic Acids Res. 1979 Nov 24;7(6):1513-23 PMID: 388356
  45. Structure of the neuraminidase gene in human influenza virus A/PR/8/34.
    Nature. 1981 Mar 19;290(5803):213-7 PMID: 7010182
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1986-03-00
Pages
1906-10
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC323193
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com